Journey Medical Corporation logo

Journey Medical Corporation

DERM | NASDAQ
Chart Builder DCF Calculator
$7.25
+$0.26 (+3.72%)
At close: Sep 22, 2026, 4:00 PM ET
$7.25
$0 (0.00%)
After-hours: Sep 22, 2026, 7:30 PM ET

Market Data

Market Cap
$192.38M
Enterprise Value
$192.27M
Beta
1.10
Average Volume
244.37K
Shares Outstanding (Diluted)
27.49M
Shares Change YoY
18.05%
Institutional Ownership
43.46%
Exchange
NASDAQ
ISIN
US48115J1097

Price Performance

Price Change 1M
-10.4%
Price Change 3M
4.3%
Price Change 6M
2.3%
Price Change YTD
-6.2%
Price Change 1Y
-4.3%
Price Change 3Y
136.9%
Price Change 5Y
-26.4%
1M CAGR (ann.)
8.7%
1Y CAGR (ann.)
-3.9%
5Y CAGR (ann.)
N/A
All-Time CAGR
-6.9%

Valuation

PE Ratio
-30.39
Forward PE
11.66
PEG Ratio
-1.47
Forward PEG
0.02
PS Ratio
2.82
Forward PS
1.50
PB Ratio
5.99
P/FCF Ratio
-25.68
P/Adj. FCF Ratio
-14.20
P/OCF Ratio
-25.89
EV/Sales
2.82
EV/EBIT
-79.42
EV/EBITDA
103.99
EV/FCF
-25.66
Earnings Yield
-3.3%
FCF Yield
-3.9%
Adj. FCF Yield
-7.0%

Financial Health

Net Cash
$102K
Total Debt
$25.54M
Cash & Short-Term Investments
$25.64M
Total Assets
$98.36M
Current Ratio
1.59
Quick Ratio
1.41
Debt / Equity Ratio
0.80
Debt / EBITDA
13.81
Debt / FCF
-3.41
OCF / Debt
-0.29
Interest Coverage
-0.82
Altman Z-Score
1.25
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
62.2%
Operating Profit Margin
-4.4%
EBITDA Margin
2.7%
Net Profit Margin
-8.9%
FCF Margin
-11.0%
Adj. FCF Margin
-19.9%
SBC / Revenue
8.9%
SBC Impact (per share)
-80.8%

Returns

Return on Assets
-6.2%
Return on Equity
-20.2%
Return on Invested Capital
-5.2%
Return on Capital Employed
-5.7%
Return on Tangible Assets
-8.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
3.5%
Revenue CAGR 5Y
6.8%
Revenue CAGR 10Y
16.7%
EPS CAGR 3Y
-52.4%
EPS CAGR 5Y
64.9%
EPS CAGR 10Y
24.1%
FCF CAGR 3Y
3.9%
FCF CAGR 5Y
34.2%
FCF CAGR 10Y
31.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
3
EPS Growth Next 3Y
323.2%
Revenue Growth Next 3Y
48.4%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
$0.02
EPS Growth Est (next Q)
-122.2%
Revenue Est (next Q)
$21.89M
Revenue Growth Est (next Q)
24.2%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$11.75
Price Target Upside
68.1%

Cash Flow

Operating Cash Flow
$-7.49M
Free Cash Flow
$-7.49M
Adj. Free Cash Flow
$-13.55M
FCF Per Share
-$0.27
OCF Per Share
-$0.27
OCF/S Ratio
-11.0%

Income Statement

Revenue
$68.18M
Gross Profit
$42.43M
Operating Income
$-3.01M
EBITDA
$1.85M
Net Income
$-6.1M
EPS (Diluted)
-$0.23
Revenue / Employee
$1.18M
Profit / Employee
$-105.24K
Employees
58

© 2026 bestshares.com. All rights reserved.